Rxo (RXO) Deferred Taxes (2021 - 2026)

Rxo (RXO) has reported Deferred Taxes for 6 consecutive years, with -$15.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Deferred Taxes fell 36.36% year-over-year to -$15.0 million; the trailing twelve-month figure through Jun 2026 stood at -$23.0 million (changed 0.0% YoY), and the FY2025 full-year result was -$21.0 million, down 10.53% from the prior year.
• Deferred Taxes retreated to -$15.0 million in Q1 2026 per RXO's latest filing, from -$6.0 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $2.0 million in Q2 2023 and bottomed at -$15.0 million in Q1 2026.
• Historically, Deferred Taxes has averaged -$5.9 million across 5 years, with a median of -$6.5 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Deferred Taxes tumbled 700.0% in 2022, then surged 57.14% in 2023.
• Over 5 years, Deferred Taxes stood at -$12.0 million in 2022, then jumped by 41.67% to -$7.0 million in 2023, then changed by 0.0% to -$7.0 million in 2024, then gained by 14.29% to -$6.0 million in 2025, then plunged by 150.0% to -$15.0 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$15.0 million, -$6.0 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.